MCL1 and cancer: In a different study, in TNBC models including MDA-MB-231 cells, MYC and MCL1 were found to cooperatively promote paclitaxel-resistant cancer stem cells by increasing OXPHOS, reactive oxygen species (ROS) production, and HIF-1α expression (28).